The CCL27 gene helps skin cells attract certain immune cells to the skin, which supports day to day defense against germs and helps control inflammation. If the CCL27 gene does not work as expected, immune cells may be guided less effectively, which can influence skin irritation, healing, and the tendency toward some inflammatory skin conditions. This gene plays an important role in keeping immune activity focused in the skin. Differences in this gene are mostly studied in skin and immune research.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or manage activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Other genes mainly help regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you react to food, stress, or medicines. For a deeper look at this topic, you can read more in the LearnHub.
Overview
CCL27Gene function
What if the gene works
The CCL27 gene helps skin cells make a chemical signal that attracts certain immune cells called T cells into the skin. This supports routine skin immune surveillance and responses to irritation or injury.
Risk
What if the gene does not work
If the CCL27 gene works poorly, skin cells may send weaker signals that attract certain immune cells into the skin. Variants can be milder or more severe, reducing signaling to different degrees or disrupting protein release.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently tailored specifically to pathogenic or loss-of-function variants in the CCL27 gene. The CCL27 pathway is being studied as a possible drug target or biomarker in inflammatory skin conditions, but this has not changed routine care.
Gene function
What if the gene works
Your skin constantly communicates with your immune system. The CCL27 gene supports this local signaling at the skin surface and helps guide certain white blood cells to the right place. This is part of how the CCL27 gene supports skin immune function in daily life.
Skin cells use the CCL27 gene to make a small messenger protein that is released in nearby tissue. This signal helps mark the skin as a place where immune cells may be needed.
Its protein helps attract certain T cells, a type of white blood cell, toward the skin. This gives those cells clear directions so they can gather where they are most useful.
By drawing the right immune cells into skin tissue, the CCL27 gene helps the body keep a steady immune watch there. This supports normal responses to everyday contact with germs, friction, and minor irritation.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variations in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CCL27 gene can change how much CCL27 protein a cell makes, how well it is released, or how strongly it binds CCR10 (a partner on the cell surface). In practice, how CCL27 gene variants affect protein function depends on the change: milder missense variants may partly weaken folding or CCR10 binding, while more severe nonsense, frameshift, or splice variants can sharply reduce secretion or stop protein production.
How variants are linked to conditions
Variants in the CCL27 gene do not yet have a broadly confirmed link to a specific health condition, and current evidence on CCL27 gene variants and disease risk is still developing. If you have a confirmed change in the CCL27 gene, your doctor or genetic counselor can explain what it may mean for you and your family based on your personal results.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are found commonly across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors play a role. In some situations, though, a single well-established variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CCL27 gene. If a genetic result involving CCL27 comes up, its meaning usually depends on the full clinical picture and other genes, so discussing personal risk with a doctor or genetic counselor can help.
Inheritance of CCL27 variants
There is not yet a broadly confirmed disease specific inheritance pattern for the CCL27 gene, so how CCL27 variants are inherited in relation to a defined medical condition is still being clarified. The CCL27 gene is located on chromosome 9, which is an autosome, so you inherit one copy from each parent. In general, changes in genes on autosomes can be passed to children of any sex.
What does my CCL27 result mean for my family?
There is not yet a broadly confirmed pattern showing that changes in the CCL27 gene cause a specific inherited condition in families. If you have a CCL27 result and want to understand what it could mean for relatives, a doctor or genetic counselor can help put that finding in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for the CCL27 gene looks for variants by reading DNA from a blood sample, cheek swab, or saliva. It is usually done as part of a multigene panel or a broader sequencing test, rather than as a stand alone test. Results may show a benign variant, an uncertain finding, or a variant that helps explain a person’s health picture.
When should I consider getting a genetic test?
There is not yet a widely used medical reason to test the CCL27 gene on its own. Decisions about genetic testing are usually based on your personal health history, skin symptoms, and family history, with guidance from a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic results can provide useful insight, yet how much they reveal varies depending on the condition and the kind of variant involved. Over time, many factors shape how the body functions, including lifestyle, environment, age, and medical history. For some conditions, particularly those influenced by many genes, genetic information provides context rather than certainty and is most helpful when considered together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect medication response. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the CCL27 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about side effects, treatment response, or other health concerns are best discussed with your doctor or pharmacist.
History
CCL27 entered the scientific literature in the late 1990s, when researchers studying skin inflammation identified a signaling molecule first called CTACK, short for cutaneous T cell attracting chemokine. Around the same time, it was also described as ESkine, reflecting early work on gene activity in skin tissue. Building on this early work, scientists uncovered more about the gene and standardized its name as the CCL27 gene within the chemokine naming system. Early studies helped connect this gene to the movement of immune cells in the skin, which made it relevant to research on inflammatory skin conditions. Over time, descriptions became more precise as gene mapping and laboratory methods improved. Although the CCL27 gene has not become a major public-facing gene, it remains part of the broader history of how scientists pieced together the skin’s immune signaling network.